Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.22NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.22NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.38NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.38NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.38.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.38.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.38.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BT.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BT.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.55NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.55NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.76NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.76NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.76NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.31NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.31NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.4.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used